NSE filing, NSE: AFIL. Summary written from the filing by ALFA Finder's alert engine.
Akme Fintrade (India) Ltd: key numbers
- Share price
- ₹7.16
- Market cap
- ₹311.4 Cr
- Revenue (annual)
- ₹148.8 Cr
- Net profit (annual)
- ₹42.32 Cr
- P/E (TTM)
- 7.0×Sector 19.8×
- Promoter holding
- 38.94%-0.08% QoQ
- FII holding
- 0.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Akme Fintrade (India) Ltd
All →Akme Fintrade (India) Results Update
Akme Fintrade's press release shows H1 FY27 PAT up 19% and AUM crossing Rs. 1,000 crore. The unaudited results were approved by the board.
Akme Fintrade (India) Q2 FY27 Results: Net Profit ₹11.9 Cr, Up 19.0% YoY
Akme Fintrade (India) Ltd reported revenue from operations of ₹45.5 Cr (+30.4% YoY) and net profit of ₹11.9 Cr (+19.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹11.9 Cr · +19.0% YoY
Akme Fintrade (India) Preferential Issue
Akme Fintrade received NSE and BSE trading approval for 82 lakh preferentially-issued equity shares. Listed capital rose to Rs. 44.79 Crore post-approval.
Akme Fintrade (India) Convertible Warrants
Akme Fintrade received NSE and BSE trading approval for 82 lakh equity shares from preferential warrant conversion. Total listed capital rose to Rs. 44.79 crore post-allotment.
Akme Fintrade (India) Board Meeting Date
Akme Fintrade intimated that its Board will meet on October 30, 2026 to approve unaudited financial results for Q2 H1 FY27. Trading window remains closed until 48 hours post-announcement.
Akme Fintrade (India) Debt & Borrowing: ₹50 Cr
Akme Fintrade's board approved ₹50 Crore secured NCD allotment in two series. Series A1 (24 months, 11.40%) and A2 (30 months, 11.60%) will be listed on NSE.
- Value
- ₹50.00 Cr
Other management change announcements
All →GAMCO Management Change
GAMCO appointed Jayshri Tulsyan as Non-Executive Independent Director for 24 months, effective October 31, 2026. Ayushi Khaitan resigned as Non-Executive Non-Independent Director, citing personal reasons.
Dhampur Bio Organics Management Change
Dhampur Bio Organics' VP Financial Planning and Analysis, Harmeet Singh, resigned, effective October 31, 2026. It is a senior management departure.
Shanthala FMCG Products Management Change
Shanthala FMCG removed CFO Yogish Mallya over alleged misappropriation of funds and appointed Ratnakar Rai as CFO. Both changes are effective 31 October 2026.
Zydus Lifesciences Management Change
Zydus Lifesciences announced the resignation of Dr. Amrut Naik, President of International Markets, effective 7 November 2026. Mr. Christoph Stoller has been appointed to the same senior management role from 2 November 2026.
Vahh Chemicals Management Change
VAHH Chemicals Limited appointed Ms. Shubhangi Rajesh Gadia as Company Secretary and Compliance Officer, effective 01 November 2026. The appointment was approved at a board meeting held on 31 October 2026.
Capital India Finance Management Change
Capital India Finance reports that Senior Management Personnel Ravindran Menon resigned, ceasing to be associated with the company from close of business on 31 October 2026. The resignation letter is enclosed.